economic evaluation

  1. SNT Gatchaman

    Quantifying all-cause healthcare resource utilization and costs of children with mild-to-moderate long COVID in France, 2025, Yang et al.

    Quantifying all-cause healthcare resource utilization and costs of children with mild-to-moderate long COVID in France Jingyan Yang; Cheikh Tamberou; Elise Arnee; Pierre-Alexandre Squara; Ayoub Boukhlal; Jennifer L. Nguyen; Hannah R. Volkman; Stephane Fievez; Marina Lepoutre-Bourguet; Haifa Ben...
  2. Dolphin

    Review Trends and Hotspots in the Health Economics Evaluation of Chronic Fatigue Syndrome, 2024, Wan

    Wan H, Wei B, Qian W, Zhang J. Trends and Hotspots in the Health Economics Evaluation of Chronic Fatigue Syndrome. J Multidiscip Healthc. 2024;17:4877-4892 https://doi.org/10.2147/JMDH.S482100...
  3. SNT Gatchaman

    Determining the societal value of a prospective drug for ME/CFS in Germany, 2024, Afschin Gandjour

    Determining the societal value of a prospective drug for ME/CFS in Germany Afschin Gandjour BACKGROUND Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) imposes a substantial societal and economic burden. The aim of this study is to ascertain the optimal level of public research and...
  4. M

    Financial Outcome Measure

    I think a financial outcome measure will be important for getting governmental funding support for bigger trials and making a case for future treatment subsidies. So it should be considered an outcome measure of improvement. There are several factors, these are 3 that spring to mind: -...
  5. Dolphin

    Trial Report The economic burden of myalgic encephalomyelitis/chronic fatigue syndrome in Australia, 2023, Zhao

    https://www.publish.csiro.au/AH/justaccepted/AH23106 Just Accepted This article has been peer reviewed and accepted for publication. It is in production and has not been edited, so may differ from the final published form. The economic burden of myalgic encephalomyelitis/chronic fatigue...
  6. rvallee

    The Economic Impacts of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in an Australian Cohort (2020) Marshall-Gradisnik et al.

    (I'm not entirely sure where to post this since it's neither biomedical nor psychosocial research...) The Economic Impacts of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in an Australian Cohort Shara Close, Sonya Marshall-Gradisnik, Joshua Byrnes, Peter Smith, Son Nghiem and Don...
    • rvallee
    • Thread
    • australia economic evaluation economic impact economics epidemiology marshall-gradisnik me/cfs
    • Replies: 7
    • Forum: ME/CFS research
  7. Andy

    Research update: The relation between ME/CFS disease burden and research funding in the USA, 2020, Mirin et al

    Paywall, https://content.iospress.com/articles/work/wor203173 Sci hub, https://sci-hub.tw/10.3233/WOR-203173
  8. Sly Saint

    Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews & economic evaluation, 2020, White et al

    Have set this up on a thread on it's own (was previously on https://www.s4me.info/threads/mus-services-in-uk-and-other-mus-related-issues.8318/ ) University of Sheffield. https://www.sheffield.ac.uk/scharr/sections/heds/mus/info...
  9. Andy

    General medical services by non-medical health professionals: a systematic quantitative review of economic evaluations in primary care, 2019, Anthony

    Paywall, https://bjgp.org/content/early/2019/04/22/bjgp19X702425 Currently not available via Sci-hub.
    • Andy
    • Thread
    • 2019 anthony economic evaluation me/cfs paper primary care
    • Replies: 4
    • Forum: ME/CFS research
Back
Top Bottom